Atypical heparin-induced thrombocytopenia complicated by intracardiac thrombus, effectively treated with ultra-low-dose rt-PA lysis and recombinant hirudin (Lepirudin)

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
K OlbrichA Greinacher

Abstract

A serious retroperitoneal bleeding occurred in a 56-year-old male patient receiving unfractionated heparin due to multiple pulmonary embolism. After reducing the heparin dose, the patient developed a new pulmonary embolism and a large thrombus in the right atrium. Concomitantly, the platelet count dropped to a value of 29 g/l. Heparin-induced thrombocytopenia (HIT) was confirmed by a functional assay, the heparin-induced platelet activation (HIPA) assay, whereas the results of a platelet factor 4/heparin complex ELISA were repeatedly negative. This indicated that the patient's HIT antibodies were directed towards an antigen other than platelet factor 4/heparin complexes. For treatment of the atrial thrombus, an ultra-low-dose lysis with rt-PA (2 mg/h, intravenously) was administered for a period of 52 h, overlapping with systemic treatment with recombinant hirudin (Lepirudin, Refludan, 0.06-0.14 mg/kg/h intravenously). The aim was to enhance lysis of the thrombus without increasing the haematoma, and at the same time keep the risk of fulminant pulmonary embolism due to thrombus fragmentation as low as possible. The cardiac thrombus disappeared within 48 h, without new signs of pulmonary embolism. Platelet counts normalized with...Continue Reading

Citations

Dec 12, 2003·The Annals of Thoracic Surgery·Theodore E Warkentin, Andreas Greinacher
Aug 7, 2003·The Annals of Thoracic Surgery·Theodore E Warkentin, Andreas Greinacher
Aug 12, 1999·British Journal of Haematology·G HuhleJ Harenberg
Jan 14, 2004·Kidney International·Katrin Annett PöschelGötz Nowak
Sep 1, 2012·Case Reports in Hematology·Atheer AhmedDavid Campbell
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·N Lubenow, A Greinacher
Dec 22, 2005·American Journal of Hematology·A Davoren, R H Aster
Mar 13, 2002·Chest·Peter S RoseDavid B Pearse
Nov 13, 2001·Reviews in Clinical and Experimental Hematology·A GreinacherV Kiefel
Mar 22, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·E BuchaH Thieler
Apr 20, 2018·BMJ Case Reports·Sriram GonakotiSudha Vidyasagar
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·N Lubenow, A Greinacher
Jun 8, 2018·Journal of Thrombosis and Thrombolysis·Eiman GhaffarpasandGerald Chi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.